Kelly Gold insider trades

Open-market stock purchases and sales by Kelly Gold, Chief Financial Officer at Camp4 Therapeutics Corp, from SEC Form 4 filings since Apr 1, 2025.

Track record: 67% of 3 scored buys are up 5% or more since purchase, averaging +61%.

Recent trades

DateStockTradeValue
Aug 31, 2026CAMP Camp4 Therapeutics CorpBought$39.6K
Aug 3, 2026CAMP Camp4 Therapeutics CorpBought$10.8K
Jul 1, 2026XFOR X4 Pharmaceuticals, IncBought (not open market)—
Apr 1, 2026CAMP Camp4 Therapeutics CorpBought (not open market)—
Dec 11, 2025CAMP Camp4 Therapeutics CorpBought (not open market)—

Companies traded

  • CAMP Camp4 Therapeutics Corp: 3 buys, last Aug 31, 2026
  • XFOR X4 Pharmaceuticals, Inc: other filings, last Jul 1, 2026

Get free alerts when Kelly Gold files a new trade →